TNF and autosomal dominant polycystic kidney disease: TNFα is considered to be a critical effector cytokine in ADPKD, and anti-TNFα therapy and targeting TNFα dependent signaling pathways have emerged in preclinical studies to have high potential in the treatment of this disease [3, 4].